CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL

Labesfal – Laboratorios Almiro, S.A. (PORTUGAL)Hanmi Fine Chemical Co. Ltd (Sterile Anhydrous Sodium Carbonate) (KOREA, REPUBLIC OF)Hanmi Fine Chemical Co. Ltd (Sterile Ceftazidime buffered with sodium carbonate) (KOREA, REPUBLIC OF)🇸🇬 Health Sciences Authority

Approval Date: Aug 25, 2016
Approval ID: 29b2f239e13d8901
Company: Labesfal – Laboratorios Almiro, S.A. (PORTUGAL)Hanmi Fine Chemical Co. Ltd (Sterile Anhydrous Sodium Carbonate) (KOREA, REPUBLIC OF)Hanmi Fine Chemical Co. Ltd (Sterile Ceftazidime buffered with sodium carbonate) (KOREA, REPUBLIC OF)
Type: Therapeutic

Approval Details

Approval Id: 29b2f239e13d8901
Drug Name: CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL
Product Name: CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL
Approval Number: SIN15075P
Approval Date: 2016-08-25
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder: FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, POWDER, FOR SOLUTION
Route Of Administration: INTRAVENOUS
Atc Code: J01DD02
Atc Item Name: ceftazidime
Pharma Manufacturer Name: FRESENIUS KABI (SINGAPORE) PTE LTD

Active Ingredients

Ceftazidime Pentahydrate eqv Ceftazidime

2000mg/vial

CEFTAZIDIME PENTAHYDRATE EQV CEFTAZIDIME

2,000 MG/VIAL

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Aug 25, 2016

Approval ID

29b2f239e13d8901

Type

Therapeutic

Back to HSA Approvals